Funding for this research was provided by:
Breast Cancer Now
Cancer Research UK (C569/A16891, C569/A10404)
Fru Berta Kamprads Stiftelse
NIHR RM/ICR Biomedical Research Centre
Skåne County Council’s Research and Development Foundation
Governmental Funding of Clinical Research within the National Health Service (ALFSKANE-350191)
Swedish Breast Cancer Association
The Inger Persson Research Foundation
Text and Data Mining valid from 2018-09-04
Received: 6 December 2017
Accepted: 8 August 2018
First Online: 4 September 2018
Ethics approval and consent to participate
: The TransATAC study was approved by the South-East London Research Ethics Committee, and all patients gave informed consent. The POLAR study was approved by the RMH Research Ethics Committee (CCR: 4122) and the ethics committee of Lund University Hospital (LU 240-01), and all patients gave informed consent.
: Not applicable.
: MCUC reports patents, royalties, other intellectual property: PAM50 patent. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.